Could TZD drugs regain lost market share?

Published: 2013-07-08 06:58:00

Updated: 2013-07-08 06:58:00

Now all eyes are on the revival of thiazolidinediones (TZDs) as Duvier (lobeglitazone), one of TZDs to treat type 2 diabetes, obtained a green light from the Ministry of Food and Drug Safety on Thursday.

Another good news recently flowed in at GlaxoSmithKline when the joint advisory committee (comprising Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Manag...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.